This article is more than 5 years old. Information may no longer be current.

VIDEO: Real-world Xen glaucoma implant technique improves on FDA-approved technique

Issue: June 25, 2017

ByDavinder S. Grover, MD, MPH

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

BALTIMORE ― At the Association for Research in Vision and Ophthalmology meeting here, Davinder S. Grover, MD, MPH, discusses an FDA-approved, prospective, open-label study of the Allergan Xen implant for the treatment of refractory glaucoma. The study looks at a less-invasive "real-world" ab interno technique than the one approved in the FDA clinical trial.